The Immunotherapies Congress 2013
Bladder Cancer Immunotherapy: Progress and Current Limitations Donald L. Lamm, MD, FACS Bladder Cancer, Genitourinary Oncology Phoenix, AZ Hebrew University.
A Blueprint to Develop a Companion Diagnostic Assay Jeff Allen, PhD Executive Director, Friends of Cancer Research.
Hemocyanins: Present and future relevance in superficial bladder carcinoma Don Lamm, M.D. Clinical Professor of Urology, University of Arizona, and Director,
Genitourinary Oncology ASCO 2009 Toni K. Choueiri, MD Dana-Farber Cancer Institute Harvard Medical School Boston, Massachusetts U.S.A.
“ Extending Prostate Cancer Survival ”
